Skip to content

Clinical trials

Completed Observational Carcinoma in Situ trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma in Situ Phase: Observational Status: Completed Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20101
20151
20171
20202

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer2
Hiantis Srl1
National Institutes of Health Clinical Center (CC)1
Orlucent, Inc1
The HIV Netherlands Australia Thailand Research Collaboration1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma in Situ6
Multiple Sclerosis2
Breast Neoplasms1
Carcinoma, Intraductal, Noninfiltrating1
Dysplastic Nevus Syndrome1
Multiple Sclerosis, Chronic Progressive1
Multiple Sclerosis, Relapsing-Remitting1
Neoplasms1
Neoplasms by Histologic Type1
Nevus1

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.